Asahi Kasei offers $1.1B for Swedish pharma Calliditas Therapeutics
Japanese conglomerate Asahi Kasei announced Tuesday that it has made a SEK 11.1 billion ($1.1 billion) offer to purchase the Swedish pharmaceutical company Calliditas Therapeutics, with its board of directors recommending that the offer be accepted.